TUCSON, Ariz. – David S. Alberts, MD, will receive the Association of Community Cancer Centers’ 2010 Clinical Research Award at ACCC’s 27th National Oncology Economics Conference Sept. 29 – Oct. 2, in St. Louis, Mo. He will be honored Sept. 30 for his extensive research, leadership and commitment to individuals with cancer. Dr. Alberts is director of the Arizona Cancer Center and Regents Professor of Medicine, Pharmacology, Nutritional Science, and Public Health at the University of Arizona.
Dr. Alberts has had a strong career focus on translational cancer prevention and treatment research. The emphasis of his laboratory-based and clinical research has been on the chemoprevention and treatment of cancers of the breast, colon, ovary and skin. Clinically, Dr. Alberts pioneered new treatments for advanced ovarian cancers, including in vitro tumor cell chemosensitivity testing for personalized medicine strategies, intraperitoneal chemotherapy, and maintenance chemotherapy.
Presently, Dr. Alberts helps to coordinate phase I and II and pharmacokinetic drug studies at the Arizona Cancer Center for molecularly targeted chemopreventive agents and anticancer drugs. His laboratory research is concentrated on the evaluation of new surrogate endpoint biomarkers for cancer prevention trials with a special focus on precursor lesions for bladder, breast, colon, cervical, endometrial, ovarian, prostate and skin cancers, using quantitative histopathology (i.e, karyometric) approaches.
During his career, Dr. Alberts has served as an advisor to numerous cancer research foundations and committees, including chair of the Oncologic Drug Advisory Committee to the U.S. Food and Drug Administration (1984-1986). He was a member of the National Cancer Institute’s Board of Counselors (to the Division of Cancer Prevention, 1990-1994), the Board of Scientific Advisors (1999-2006), and was on the coordinating subcommittee to the Clinical Translational Advisory Committee, NCI (2006-2009). In June 2001, he was acknowledged by Science to be one of the top three National Institutes of Health-funded clinical researchers in the United States. In 2003 the American Association for Cancer Research (AACR) recognized his contributions to clinical care in the field of cancer with the Joseph H. Burchenal Clinical Research Award, and in 2004 the American Society for Preventive Oncology gave him its Distinguished Career Award for research excellence. Also in 2004, the AACR awarded Dr. Alberts with its AACR-Cancer Research and Prevention Foundation Award for Excellence in Cancer Prevention Research Worldwide.
Dr. Alberts has authored or co-authored more than 500 peer-reviewed publications, more than 100 book chapters and 60 invited articles, and has served as editor and co-editor of six books, including Fundamentals of Cancer Prevention, Second Edition, Springer Verlag, 2009, and Intraperitoneal Therapy for Ovarian Cancer, Springer Verlag, 2010. He has served on the editorial boards of several peer-reviewed scientific journals, including as associate editor for Cancer Research from 1989-2002. Between 2002 and 2008, he acted as the co-editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention, the leading cancer public health research journal worldwide.
Dr. Alberts received his medical degree from University of Virginia School of Medicine. He conducted his internship at the University of Wisconsin, before becoming a clinical associate in medical oncology at NCI’s Baltimore Cancer Research Center. Dr. Alberts conducted his internal medicine residency at the University of Minnesota and then served on the faculty of the University of California, San Francisco, for five years and obtained board certification in medicine and medical oncology.
Among the past winners of ACCC’s prestigious annual Outstanding Achievement in Clinical Research Award are Charles M. Balch, MD, FACS; David H. Johnson, MD; Lillian M. Nail, PhD, RN, FAAN; former Arizona Cancer Center Director Daniel D. Von Hoff, MD, FACP; Saul Rivkin, MD; Henry Lynch, MD; and Vincent DeVita, Jr, MD.
The Association of Community Cancer Centers (ACCC) provides a national forum for addressing issues that affect community cancer programs, such as regulatory and legislative issues, measurements of the quality of care, and clinical research. Nearly 17,000 cancer care professionals from approximately 900 hospitals and more than 1,200 private practices are affiliated with ACCC. It is estimated that 60 percent of cancer patients nationwide are treated by a member of ACCC. Its unique membership of more than 670 hospital cancer programs and oncology private practices includes all members of the cancer care team: medical and radiation oncologists, surgeons, cancer program administrators and medical directors, pharmacists, oncology nurses, oncology social workers, and cancer program data managers. For more information, visit ACCC’s website at www.accc-cancer.org.
The Arizona Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center headquartered in Arizona. With primary locations at the University of Arizona in Tucson, the Cancer Center has more than a dozen research and education offices in Phoenix and throughout the state and 300 physician and scientist members working together to prevent and cure cancer. For more information, go to www.arizonacancercenter.org.